Best Biopharma Outsourcing Companies in Canada
The 203 best Biopharma Outsourcing companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: adMare BioInnovations.
Canada's Biopharma Outsourcing sector is more competitive than most people realize, and this directory ranks 203 companies operating across the country by disclosed equity funding and recent funding momentum. Total disclosed capital sits at $306M, with AtomVie leading the pack at $90M, well ahead of ImmunoPrecise Antibodies at $18M and LSL Pharma Group at $13M. No unicorns yet, but the funding spread tells you something about where the real activity is concentrated. The global market behind all this hit $28.7B in 2024 and is forecast to reach $112.3B by 2032, a CAGR of 5.8% driven by biologics demand and rising drug development costs. As shown in 2015 research, outsourcing decisions in biopharma have long tracked closely with cost-pressure cycles, and that dynamic is only accelerating now.
So what's moving the needle this quarter? Clinical trial outsourcing and operational resilience are the themes I keep seeing gain traction, and median app install growth of roughly 13% year-over-year across outsourcing platforms confirms the sector's digital engagement is real. Regulatory compliance pressure is tightening too, which tends to push more sponsors toward specialized CROs rather than building capacity in-house. Investors like FedDev Ontario and Boomerang Capital are circling this space. If you're benchmarking providers, the funding gaps between tiers here are wide enough to matter.
- ResearchAndMarkets.com
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Canada
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | adMare BioInnovations Provider of biopharma consulting services | $92M | 50 mo ago | 152 | 2019 | — | SentryPHPVimeo+23 | 4 patents Small‑molecule therapeutics targeting bone formation disorders (FOP, Cyp26b1 inhibition). | 1 job opening · 1 internship · 1 expansion |
| 2 | AtomVie Provider of diversified CDMO services for radiotherapeutics | $90M | 36 mo ago | 92 | 2021 | — | WordPressApple iCloud MailMicrosoft 365+19 | — | 5 job openings · 1 expansion |
| 3 | Therapure Biopharma Contract development and manufacturing organization that specializes in the development, manufacture of… | $24M | 129 mo ago | 225 | 2008 | — | — | 52 patents Hemoglobin-targeted drug carriers and large‑scale protein/albumin purification technologies | — |
| 4 | ImmunoPrecise Antibodies CDMO focused on antibody discovery and pre-clinical services | $18M | 23 mo ago | 80 | 1989 | Chris Buyse Board of Directors | Cart FunctionalityWooCommerceWordPress+23 | 5 patents Monoclonal antibody production and diagnostics for estrogen receptors and muscular dystrophy biomarkers | — |
| 5 | LSL Pharma Group Integrated pharmaceutical company provides pharma products | $13M | 9 mo ago | — | 2023 | Francois Roberge CEO | WixSentryBootstrap+10 | — | 2 launchs |
| 6 | High Q Technologies Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis | $10M | 27 mo ago | 24 | 2013 | Wendy Hinchey CEO | — | — | 1 job opening · 1 partnership |
| 7 | Contract Pharmaceuticals CDMO focused on manufacturing of semi-solid pharmaceutical drugs | $9M | 132 mo ago | 325 | 1991 | Ken Paige CEO | WordPressMySQLPHP+19 | 38 patents Pharmaceutical dosage packaging, consumable storage vessels, and pyrethroid spray formulation technologies. | — |
| 8 | CryoStasis Developer of subzero unfrozen cell preservation platform for cell and gene therapy | $8M | 34 mo ago | 8 | 2022 | — | — | 10 patents Cryogenic preservation and storage systems for biological specimens and tissues | — |
| 9 | CellCarta CRO focused on providing histopathology and genomics services | $8M | 141 mo ago | 727 | 2002 | Dirk Hendriks Co-Founder | WordPressPleskApple iCloud Mail+17 | — | — |
| 10 | Sirona Biochem Developer of therapeutics for the treatment of skincare | $7M | 13 mo ago | 11 | 2006 | Howard Verrico CEO | WordPressMySQLPHP+26 | — | — |
| 11 | Biomind Labs Developer of novel pharmaceuticals targeting neurological disorders and related conditions | $6M | 56 mo ago | 5 | 2005 | — | — | 9 patents Patents concentrated in chemistry & materials | — |
| 12 | Voyageur Pharmaceuticals Manufacturer of barium and iodine generic radiographic drugs | $4M | 16 mo ago | — | 2013 | Brent Willis CEO & Director | — | — | — |
| 13 | Arthritis Research Canada Company conducting and coordinating clinical trials for arthritis treatment | $3M | 141 mo ago | 68 | 2000 | John Esdaile Founder | WordPressMySQLPHP+37 | — | 1 job opening |
| 14 | Neurenati Biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung… | $3M | 26 mo ago | — | 2020 | Maxime Ranger CEO | WordPress Block EditorWordPressMySQL+19 | — | — |
| 15 | Radient Technologies Develops and markets high-value naturally derived plant extracts | $3M | 38 mo ago | 50 | 2001 | — | — | 6 patents Extraction and purification of natural bioactive alkaloids for pharmaceutical use. | — |
| 16 | CEN Biotech Holding company focused on hemp based healthcare services & products | $3M | 122 mo ago | 4 | 2013 | Joseph Byrne CEO | — | — | — |
| 17 | Liberum Provider of protein synthesizers manufacturing, pre-clinical research, and drug development services among… | $2M | 34 mo ago | 3 | 2019 | — | — | — | — |
| 18 | Quality Green Provider of medical cannabis | $2M | 90 mo ago | 11 | 2015 | Andrew Spasiw CEO | — | — | — |
| 19 | Andira Digital pharmacotherapeutic platform for providers 21Funding top 50%Talent bottom 49%Market bottom 37%Global bottom 29% All 4 signals ▾Fundingtop 50% Talentbottom 49% Marketbottom 37% Globalbottom 29% Funding: Raised $1.4M across 5 rounds · 5 rounds over 4 yrs (1.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $1M | 3 mo ago | — | 2020 | Dana Lambert Chief Executive Officer | — | — | — |
| 20 | PragmaClin Provider of drug research & development services for neurological diseases | $249K | 48 mo ago | 10 | 2020 | Gord Genge Co-Founder | — | — | — |
Top 12 Biopharma Outsourcing companies in Canada
#1
Public · Boucherville, Quebec · founded 2023$12.6Mraised▾
Groupe LSL Pharma is a Canadian integrated pharmaceutical company that focuses on innovation in life science products to support the Canadian population. They have recently announced new orders with an annual revenue potential exceeding $2.6 million.
- Sep 2025Post IPO$1.7M
- Dec 2024Post IPO—
- Jul 2024Post IPO$960K
- Jun 2024Post IPO$1.1M
#2
Seed · Vancouver, British Columbia · founded 2020$1.4Mraised▾
Digital pharmacotherapeutic platform for providers. It is a platform for the discovery and creation of natural chemicals with the potential for medicinal usage.
- Feb 2026Seed$152.4K
- Aug 2024Seed$809.9K
- Jun 2024Seed$18.3K
- Oct 2023Seed$212K
#3
Public · Vancouver, British Columbia · founded 2006 · 11 employees$7.4Mraised▾
Developer of therapeutics for the treatment of skincare. The company is developing anti-aging and anti-wrinkle molecule, TFC-1326, as GlycoProteMim to preserve and restore youthful skin and reverse aging.
- Apr 2025Post IPO$2.2M
- Apr 2024Post IPO$97.8K
- Jul 2019Post IPO$1.1M
- Feb 2019Post IPO$1.8M
#4
Public · Victoria, British Columbia · founded 1989 · 80 employees$18.4Mraised▾
CDMO focused on antibody discovery and pre-clinical services
- Jul 2024Post IPO$2M
- Jul 2020Grant (prize money)—
- Apr 2020Post IPO$1.8M
- Apr 2020Grant (prize money)$75K
#5
Public · Calgary, Alberta · founded 2013$3.9Mraised▾
Manufacturer of barium and iodine generic radiographic drugs
- Feb 2025Grant (prize money)$416.6K
- Dec 2024Post IPO$639.8K
- Dec 2024Post IPO$353.2K
- Jan 2024Post IPO$488.5K
#6
Series A · Hamilton, Ontario · founded 2021 · 92 employees$90Mraised▾
Provider of diversified CDMO services for radiotherapeutics
- Jun 2023Series A—
- Aug 2022Series A$90M
#7
Funding Raised · Vancouver, British Columbia · founded 2019 · 152 employees$92Mraised▾
Provider of biopharma consulting services
- Mar 2022Grant (prize money)$92M
#8
Seed · Waterloo, Ontario · founded 2013 · 24 employees$10.2Mraised▾
Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis. The company’s systems resolve complex problems in protein dynamics for drug discovery. It offers a sample measurement service to provide researchers with insights into molecular dynamics. The organization’s technology aims to redefine standards in protein structure determination.
- Feb 2024Seed$3.8M
- 2019Seed$6.5M
#9
Seed · Montreal, Quebec · founded 2020$2.9Mraised▾
Neurenati Therapeutics is a biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung disease. The company recently concluded a $1.2 million seed financing round to advance the development of their NEU-001 therapy. CEO Maxime Ranger is a serial entrepreneur and venture capitalist in the life science space.
- Apr 2024Seed$1.7M
- Feb 2024Seed$1.2M
#10
Seed · Ottawa, Ontario · founded 2022 · 8 employees$8Mraised▾
Developer of subzero unfrozen cell preservation platform for cell and gene therapy. The company’s platform uses media, temperature, and pressure to preserve biological material. The media formulation leverages cold shock inhibitors and membrane protectants. Temperature systems include devices and shipping solutions. Pressure systems lower the freezing point and cell metabolism, enabling long-term storage.
- Jul 2023Seed$8M
#11
Public · Edmonton, Alberta · founded 2001 · 50 employees$2.6Mraised▾
Radient Technologies operates in the business of extraction, purification and isolation compounds, and ingredients from plants for use in the production of pharmaceutical intermediates, nutraceuticals, foods, and cosmetic products. The products include valerenic acid, flax SDG, and carnosic acid. Radient produces these high-value natural substances by uniquely combining MAP (Microwave Assisted Processing), a patented extraction technology and their knowledge in the downstream processing areas of purification and extraction.
- Apr 2023Post IPO$29.8K
- Jun 2022Post IPO—
- Dec 2021Post IPO$1.3M
- Oct 2020Post IPO—
#12
Seed · Toronto, Ontario · founded 2019 · 3 employees$2Mraised▾
Developer of a biotechnology platform intended to democratize access to the fruits of synthetic biology. The company's platform uses proprietary molecular and hardware technology, protein synthesizers help to speed up the production of enzymes, therapeutics, and lab reagents, enabling clients to bring speed, scalability, and reduce cost.
- Jul 2023Seed$1.8M
- Jun 2020Seed$250K
Funding & investor landscape
Notable founders
How research on Biotechnology is moving in Canada
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 990 Canada-affiliated papers.
- Ministry of Agriculture118
- Ministry of Education70
- University of Toronto61
- McGill University60
- Agriculture and Agri-Food Canada58
- Gene3→32
- Mutant2→13
- Genome2→12
- Transcription factor2→11
- Transcription (linguistics)1→9
- Gene2→40
- Fermentation1→12
- Antimicrobial1→9
- Population1→9
- Agriculture1→8
- Agriculture3→10
- Antibiotic resistance3→10
- Antimicrobial1→6
- Human health2→7
- Microbiome2→6
Where biotechnology is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Canada
Canada biotechnology patent filing is accelerating — 18,553 filings from 8,000 assignees (2016–2025), led by UNIV British Columbia, UNIV Health Network, NAT RES Council Canada; annual filings 1716→1734.
- UNIV British Columbia1570
- UNIV Health Network1208
- NAT RES Council Canada900
- UNIV Alberta753
- CA NAT Research Council699
- Medicago680
- UNIV Saskatchewan597
- Zymeworks594
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.